{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:45:09Z","timestamp":1767847509540,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s11883-009-0052-4","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T11:28:11Z","timestamp":1249039691000},"page":"343-349","source":"Crossref","is-referenced-by-count":10,"title":["Low-density lipoprotein in the setting of congestive heart failure: Is lower really better?"],"prefix":"10.1007","volume":"11","author":[{"given":"Tamara","family":"Horwich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"52_CR1","first-page":"e21","volume":"119","author":"D. Lloyd-Jones","year":"2009","unstructured":"Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart Disease and Stroke Statistics-2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21\u2013e181","journal-title":"Circulation"},{"key":"52_CR2","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199006143222403","volume":"322","author":"J. Pekkanen","year":"1990","unstructured":"Pekkanen J, Linn S, Heiss G, et al.: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990, 322:1700\u20131707.","journal-title":"N Engl J Med"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","volume":"161","author":"J. He","year":"2001","unstructured":"He J, Ogden LG, Bazzano LA, et al.: Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001, 161:996\u20131002.","journal-title":"Arch Intern Med"},{"key":"52_CR4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D. Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, et al.: The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557\u20131562.","journal-title":"JAMA"},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"J.K. Adams","year":"2005","unstructured":"Adams JK, Fonarow GC, Emerman CL, et al.: Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209\u2013216.","journal-title":"Am Heart J"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.188965","volume":"117","author":"D.D. Schocken","year":"2008","unstructured":"Schocken DD, Benjamin EJ, Fonarow GC, et al.: Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117:2544\u20132565.","journal-title":"Circulation"},{"key":"52_CR7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0002-8703(91)90225-7","volume":"1213Pt1","author":"W.B. Kannel","year":"1991","unstructured":"Kannel WB, Belanger AJ: Epidemiology of heart failure. Am Heart J 1991, 121(3 Pt 1):951\u2013957.","journal-title":"Am Heart J"},{"key":"52_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1071-9164(97)90022-1","volume":"3","author":"J. Kjekshus","year":"1997","unstructured":"Kjekshus J, Pedersen TR, Olsson AG, et al.: The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail 1997, 3:249\u2013254.","journal-title":"J Card Fail"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"53T","DOI":"10.1016\/S0002-9149(98)00727-9","volume":"82","author":"T.R. Pedersen","year":"1998","unstructured":"Pedersen TR: Coronary artery disease: the Scandinavian Simvastatin Survival Study experience. Am J Cardiol 1998, 82:53T\u201356T.","journal-title":"Am J Cardiol"},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2006.03.034","volume":"47","author":"B.M. Scirica","year":"2006","unstructured":"Scirica BM, Morrow DA, Cannon CP, et al.: Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. J Am Coll Cardiol 2006, 47:2326\u20132331.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0002-9149(98)00334-8","volume":"82","author":"D.L. Vredevoe","year":"1998","unstructured":"Vredevoe DL, Woo MA, Doering LV, et al.: Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1998, 82:323\u2013328.","journal-title":"Am J Cardiol"},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1054\/jcaf.2002.0804216","volume":"8","author":"T.B. Horwich","year":"2002","unstructured":"Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC: Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002, 8:216\u2013224.","journal-title":"J Card Fail"},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0167-5273(00)00224-2","volume":"76","author":"M. Rauchhaus","year":"2000","unstructured":"Rauchhaus M, Koloczek V, Volk HD, et al.: Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol 2000, 76:125\u2013133.","journal-title":"Int J Cardiol"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2003.07.016","volume":"42","author":"M. Rauchhaus","year":"2003","unstructured":"Rauchhaus M, Clark AL, Doehner W, et al.: The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003, 42:1933\u20131940.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ahj.2006.06.015","volume":"152","author":"N. Afsarmanesh","year":"2006","unstructured":"Afsarmanesh N, Horwich TB, Fonarow GC: Total cholesterol levels and mortality risk in nonischemic systolic heart failure. Am Heart J 2006, 152:1077\u20131083.","journal-title":"Am Heart J"},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ahj.2008.07.004","volume":"156","author":"T.B. Horwich","year":"2008","unstructured":"Horwich TB, Hernandez AF, Dai D, et al.: Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. Am Heart J 2008, 156:1170\u20131176.","journal-title":"Am Heart J"},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/ehi195","volume":"27","author":"M. Christ","year":"2006","unstructured":"Christ M, Klima T, Grimm W, et al.: Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2006, 27:691\u2013699.","journal-title":"Eur Heart J"},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2003.11.039","volume":"43","author":"K. Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43:1439\u20131444.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1525-139X.2007.00346.x","volume":"20","author":"T.B. Horwich","year":"2007","unstructured":"Horwich TB, Fonarow GC: Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial 2007, 20:549\u2013553.","journal-title":"Semin Dial"},{"key":"52_CR20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ahj.2007.11.043","volume":"155","author":"T.B. Horwich","year":"2008","unstructured":"Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC: Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008, 155:883\u2013889.","journal-title":"Am Heart J"},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","volume":"349","author":"S.D. Anker","year":"1997","unstructured":"Anker SD, Ponikowski P, Varney S, et al.: Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349:1050\u20131053.","journal-title":"Lancet"},{"key":"52_CR22","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","volume":"103","author":"A. Deswal","year":"2001","unstructured":"Deswal A, Petersen NJ, Feldman AM, et al.: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001, 103:2055\u20132059.","journal-title":"Circulation"},{"key":"52_CR23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.amjcard.2006.03.046","volume":"98","author":"H.T. May","year":"2006","unstructured":"May HT, Muhlestein JB, Carlquist JF, et al.: Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure. Am J Cardiol 2006, 98:653\u2013658.","journal-title":"Am J Cardiol"},{"key":"52_CR24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(00)02690-8","volume":"356","author":"M. Rauchhaus","year":"2000","unstructured":"Rauchhaus M, Coats AJ, Anker SD: The endotoxin-lipoprotein hypothesis. Lancet 2000, 356:930\u2013933.","journal-title":"Lancet"},{"key":"52_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2004.10.009","volume":"179","author":"C.H. Strey","year":"2005","unstructured":"Strey CH, Young JM, Molyneux SL, et al.: Endotheliumameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. Atherosclerosis 2005, 179:201\u2013206.","journal-title":"Atherosclerosis"},{"key":"52_CR26","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","volume":"21","author":"M. Takemoto","year":"2001","unstructured":"Takemoto M, Liao JK: Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001, 21:1712\u20131719.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"52_CR27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.CIR.102.6.611","volume":"102","author":"B.F. Uretsky","year":"2000","unstructured":"Uretsky BF, Thygesen K, Armstrong PW, et al.: Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 2000, 102:611\u2013616.","journal-title":"Circulation"},{"key":"52_CR28","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.105.552174","volume":"112","author":"L. Gao","year":"2005","unstructured":"Gao L, Wang W, Li YL, et al.: Simvastatin therapy normalizes sympathetic neural control in experimental heart failure. roles of angiotensin ii type 1 receptors and NAD(P)H oxidase. Circulation 2005, 112:1763\u20131770","journal-title":"Circulation"},{"key":"52_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.CIR.104.3.317","volume":"104","author":"R. Patel","year":"2001","unstructured":"Patel R, Nagueh SF, Tsybouleva N, et al.: Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001, 104:317\u2013324.","journal-title":"Circulation"},{"key":"52_CR30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jacc.2003.07.049","volume":"43","author":"T.B. Horwich","year":"2004","unstructured":"Horwich TB, MacLellan WR, Fonarow GC: Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 2004, 43:642\u2013648.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR31","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.296.17.2105","volume":"296","author":"A.S. Go","year":"2006","unstructured":"Go AS, Lee WY, Yang J, et al.: Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA 2006, 296:2105\u20132111.","journal-title":"JAMA"},{"key":"52_CR32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.165.1.62","volume":"165","author":"J.G. Ray","year":"2005","unstructured":"Ray JG, Gong Y, Sykora K, Tu JV: Statin use and survival outcomes in elderly patients with heart failure. Arch Intern Med 2005, 165:62\u201367.","journal-title":"Arch Intern Med"},{"key":"52_CR33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.104.519876","volume":"112","author":"H. Fukuta","year":"2005","unstructured":"Fukuta H, Sane DC, Brucks S, Little WC: statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 2005, 112:357\u2013363.","journal-title":"Circulation"},{"key":"52_CR34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","volume":"108","author":"K. Node","year":"2003","unstructured":"Node K, Fujita M, Kitakaze M, et al.: Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003, 108:839\u2013843.","journal-title":"Circulation"},{"key":"52_CR35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","volume":"47","author":"S. Sola","year":"2006","unstructured":"Sola S, Mir MQ, Lerakis S, et al.: Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 2006, 47:332\u2013337.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacc.2005.06.087","volume":"47","author":"B.E. Bleske","year":"2006","unstructured":"Bleske BE, Nicklas JM, Bard RL, et al.: Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level. J Am Coll Cardiol 2006, 47:338\u2013341.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2006.09.008","volume":"13","author":"H. Krum","year":"2007","unstructured":"Krum H, Ashton E, Reid C, et al.: Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, proinflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure. J Card Fail 2007, 13:1\u20137.","journal-title":"J Card Fail"},{"key":"52_CR38","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","volume":"357","author":"J. Kjekshus","year":"2007","unstructured":"Kjekshus J, Apetrei E, Barrios V, et al.: Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007, 357:2248\u20132261.","journal-title":"N Engl J Med"},{"key":"52_CR39","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","volume":"372","author":"GISSI-HF Investigators, Tavazzi L, Maggioni AP","year":"2008","unstructured":"GISSI-HF Investigators, Tavazzi L, Maggioni AP, et al.: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1231\u20131239.","journal-title":"Lancet"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-009-0052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-009-0052-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-009-0052-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:35:35Z","timestamp":1559432135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-009-0052-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s11883-009-0052-4","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,1]]}}}